Enhanced expression of Tie2, its ligand angiopoietin-1, vascular endothelial growth factor, and CD31 in human non-small cell lung carcinomas

Clinical Cancer Research

Volumn 5, Issue 9, 1999, Pages 2506-2510

  Takahama, Makoto ^a   Tsutsumi, Masahiro ^a   Tsujiuchi, Toshifumi ^a   Nezu, Kunimoto ^a   Kushibe, Keiji ^a   Taniguchi, Shigeki ^a   Kotake, Yashige ^b   Konishi, Yoichi ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

^b OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD31 ANTIGEN; ENDOGLIN; LIGAND; MESSENGER RNA; PROTEIN TYROSINE KINASE; THROMBIN RECEPTOR; VASCULOTROPIN;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CLINICAL ARTICLE; FEMALE; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LARGE CELL CARCINOMA; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MALE; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; ANGIOPOIETIN-1; ANTIGENS, CD31; BIOLOGICAL MARKERS; CARCINOMA, NON-SMALL-CELL LUNG; ENDOTHELIAL GROWTH FACTORS; FEMALE; HUMANS; LIGANDS; LUNG NEOPLASMS; LYMPHOKINES; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, TIE-2; RIBONUCLEASES; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0032884777     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Landis, S. H., Murray, T., Bolden, A., and Wingo, P. A. Cancer statistics, 1998 (published erratum appears in CA Cancer J. Clin., 48: 192, 1998). CA Cancer J. Clin., 48: 6-29, 1998.
2. Ahrendt, S. A., Chow, J. T., Xu, L-H., Yang, S. C., Eisenberger, C. F., Esteller, M., Herman, J. G., Wu, L., Decker, P. A., Jen, J., and Sidransky, D. Molecular detection of tumor cells in bronchoalveolar lavage fluid from patients with early stage lung cancer. J. Natl. Cancer Inst., 91: 332-339, 1999.
3. Naruke, T., Goya, T., Tsuchiya, R., and Suemasu, K. Prognosis and survival in resected lung carcinoma based on the new international staging system (published erratum appears in J. Thorac. Cardiovasc. Surg., 97: 350, 1989). J. Thorac. Cardiovasc. Surg., 96: 440-447, 1988.
4. Konishi, H., Takahashi, T., Kozaki, K., Yatabe, Y., Mitsudomi, T., Fujii, Y., Sugiura, T., Matsuda, H., Takahashi, T., and Takahashi, T. Detailed deletion mapping suggests the involvement of a tumor suppressor gene at 17p13.3, distal to p53, in the pathogenesis of lung cancers. Oncogene, 17: 2095-2100, 1998.
5. Tomizawa, Y., Nakajima, T., Kohno, T., Saito, R., Yamaguchi, N., and Yokota, J. Clinicopathological significance of Fhit protein expression in stage I non-small cell lung carcinoma. Cancer Res., 58: 5478-5483, 1998.
6. Mao, L., Lee, J. S., Kurie, J. M., Fan, Y. H., Lippman, S. M., Lee, J. J., Ro, J. Y., Broxson, A., Yu, R., Morice, R. C., Kemp, B. L., Khuri, F. R., Walsh, G. L., Hittelman, W. N., and Hong, W. K. Clonal genetic alterations in the lungs of current and former smokers. J. Natl. Cancer Inst., 89: 857-862, 1997.
7. Ohta, Y., Endo, Y., Tanaka, M., Shimizu, J., Oda, M., Hayashi, Y., and Watanabe, Y. Significance of vascular endothelial growth factor messenger RNA expression in primary lung cancer. Clin. Cancer Res., 2: 1411-1416, 1996.
8. Takanami, I., Tanaka, F., Hashizume, T., and Kodaira, S. Vascular endothelial growth factor and its receptor correlate with angiogenesis and survival in pulmonary adenocarcinoma. Anticancer Res., 17: 2811-2814, 1997.
9. Mattern, J., Koomagi, R., and Volm, M. Vascular endothelial growth factor expression and angiogenesis in non-small cell lung carcinomas. Int. J. Oncol., 6: 1059-1062, 1995.
10. Schnurch, H., and Risau, W. Expression of tie-2, a member of a novel family of receptor tyrosine kinases, in the endothelial lineage. Development (Camb.), 119: 957-968, 1993.
11. Maisonpierre, P. C., Goldforb, M., Yancopoulos, G. D., and Gao, G. Distinct rat genes with related profiles of expression define a TIE receptor tyrosine kinase family. Oncogene, 8: 1631-1637, 1993.
12. Sato, T. N., Tozawa, Y., Deutsch, U., Wolburg-Buchholz, K., Fujiwara, Y., Gendron-Maguire, M., Gridley, T., Wolburg, H., Risau, W., and Quin, Y. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature (Lond.), 376: 70-74, 1995.
13. Kaipaimen, A., Vlaykova, T., Hatva, E., Bohling, T., Jekunen, A., Pyrhonen, S., and Alitalo, K. Enhanced expression of the tie receptor tyrosine kinase messenger RNA in the vascular endothelium of metastatic melanomas. Cancer Res., 54: 6571-6577, 1994.
14. Hatva, E., Kaipaimen, A., Jaaskelainen, J., Paetau, A., Haltia, M., and Alitalo, K. Expression of endothelial cell-specific receptor tyrosine kinases and growth factors in human brain tumors. Am. J. Pathol., 146: 368-378, 1995.
15. Peters, K. G., Coogan, A., Berry, D., Marks, J., Iglehart, J. D., Kontos, C. D., Rao, P., Sankar, S., and Trogan, E. Expression of Tie2/Tek in breast tumor vasculature provides a new marker for evaluation of tumor angiogenesis. Br. J. Cancer, 77: 51-56, 1998.
16. Davis, S., Aldrich, T. H., Jones, P. F., Acheson, A., Compton, D. L., Jain, V., Ryan, T. E., Bruno, J., Radziejewski, C., Maisonpierre, P. C., and Yancopoulos, G. D. Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell, 87: 1161-1169, 1996.
17. Maisonpierre, P. C., Suri, C., Jones, P. F., Bartunkova, S., Wiegand, S. J., Radziejewski, C., Compton, D., McClain, J., Aldrich, T. H., Papadopoulos, N., Daly, T. J., Davis, S., Sato, T. N., and Yancopoulos, G. D. Angiopoitin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science (Washington DC), 277: 55-60, 1997.
18. Hanahan, D., and Folkman, J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell, 86: 353-364, 1996.
19. Folkman, J. Antiangiogenic gene therapy. Proc. Natl. Sci. USA, 95: 9064-9066, 1998.
20. Mattern, J., Koomagi, R., and Volm, M. Vascular endothelial growth factor expression and angiogenesis in non-small cell lung carcinomas. Int. J. Oncol., 6: 1059-1062, 1995.
21. Takahama, M., Tsutsumi, M., Tsujiuchi, T., Kido, A., Sakitani, H., Iki, K., Taniguchi, S., Kitamura, S., and Konishi, Y. Expression of vascular endothelial growth factor and its receptors during lung carcinogenesis by N-nitrosobis(2-hydroxypropyl)amine in rats. Mol. Carcinogenesis, 24: 287-293, 1999.
22. Yoshiji, H., Kuriyama, S., Yoshii, J., Yamazaki, M., Kikukawa, M., Tsujinoue, H., Nakatani, T., and Fukui, H. Vascular endothelial growth factor tightly regulates in vivo development of murine hepatocellular carcinoma cells. Hepatology, 28: 1489-1496, 1998.
23. UICC. TNM Classification of Malignant Tumors, Ed. 5, pp. 93-97. New York: Wiley-Liss, 1997.
24. Nakae, D., Kobayashi, Y., Akai, H., Andoh, N., Satoh, H., Ohashi, K., Tsutsumi, M., and Konishi, Y. Involvement of 8-hydroxyguanine formation in the initiation of rat liver carcinogenesis by low dose levels of. N-nitrosodiethylamine. Cancer Res., 57: 1281-1287, 1997.
25. Hanahan, D. Signaling vascular morphogenesis and maintenance. Science (Washington DC), 277: 48-50, 1997.
26. Folkman, J., and D'Amore, P. A. Blood vessel formation: what is its molecular basis? Cell, 87: 1153-1155, 1996.
27. Klagsbrun, M., and D'Amore, P. A. Regulation of angiogenesis. Annu. Rev. Physiol., 53: 217-239, 1991.
28. Folkman, J. Tumor angiogenesis. In: J. Mendelsohn, P. Howley, L. A. Liotta, and M. Israel (eds.), The Molecular Basis of Cancer, pp. 206-232. Philadelphia: W. B. Saunders, 1995.
29. Craft, P. S., and Harris, A. L. Clinical prognostic significance of tumor angiogenesis. Ann. Oncol., 5: 305-311, 1994.
30. Sato, T. N., Qin, Y., Kozak, C. A., and Audus, K. L. tie-1 and tie-2 define another class of putative receptor tyrosine kinase genes expressed in early embryonic vascular system. Proc. Natl. Acad. Sci. USA, 90: 9355-9358, 1993.
31. Koblizek, T. I., Weiss, C., Yancopoulos, G. D., Deutsch, U., and Risau, W. Angiopoietin-1 induces sprouting angiogenesis in vitro. Curr. Biol., 8: 529-532, 1998.
32. Senger, D. R., Galli, S. J., Dvorak, A., M., Perruzzi, C. A., Harvey, V. S., and Dvorak, H. F. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science (Washington DC), 219: 983-985, 1983.
33. Leung, D. W., Cachianes, G., Kuang, W. J., Goeddel, D. V., and Ferrara, N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science (Washington DC), 246: 1306-1309, 1989.
34. Takahama, M., Tsutsumi, M., Tsujiuchi, T., Kido, A., Okajima, E., Nezu, K., Tojo, T., Kushibe, K., Kitamura, S., and Konishi, Y. Frequent expression of the vascular endothelial growth factor in human non-small cell lung cancers. Jpn. J. Clin. Oncol., 27: 176-181, 1998.
35. Lin, P., Polverini, P., Dewhirst, M., Shan, S., Rao, P. S., and Peters, K. G. Inhibition of tumor angiogenesis using a soluble receptor establishes a role for Tie-2 in pathologic vascular growth. J. Clin. Invest., 100: 2072-2078, 1997.
36. Kim, K. J., Li, B., Winer, J., Armanini, M., Gillett, N., Phillips, H. S., and Ferrara, N. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo. Nature (Lond.), 362: 841-844, 1993.
37. Asahara, T., Chen, D., Takahashi, T., Fujikawa, K., Kearney, M., Magner, M., Yancopoulos, G. D., and Isner, J. M. Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization. Circ. Res., 83: 233-240, 1998.